Skip to content
ROIVANT SCIENCES LTD

Greenlight Capital ROIVANT SCIENCES LTD transactions over time

ROIV

ROIVANT SCIENCES LTD historical holders

total: 3

Transactions details

Total transactions:
10
New positions:
1
Added:
4
Reduced:
5
Held for:
0 quarters
Latest activity:
2026 Q3
David Einhorn has been an institutional investor in ROIVANT SCIENCES LTD (ROIV) since 2024 Q1. According to 2026 Q3 report, David Einhorn holds 1,131,747 shares with a market value of roughly $41.39M representing 1.16% of their equity portfolio. The fund/company first acquired ROIV in 2024 Q1, initially purchasing about 4.19M shares. Since the initial investment, Greenlight Capital has made 9 more transactions in this position.

Does David Einhorn still hold ROIV?

Yes, David Einhorn continues to hold ROIVANT SCIENCES LTD (ROIV). According to their 2026 Q3 report, they maintain a position of 1,131,747 shares valued at approximately $41.39M, representing 1.16% of their equity portfolio.

When did David Einhorn first invest in ROIV?

David Einhorn first invested in ROIVANT SCIENCES LTD (ROIV) in 2024 Q1 at the reported quarter-end price of $10.54 per share, acquiring 4,190,490 shares in their initial purchase.

ROIV transactions history by Greenlight Capital

10 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
1.16%
1,131,747
$36.57
$41,387,988
-47.43% (-1,020,922)
-0.96%
2026 Q1
1.87%
2,152,669
$27.70
$59,628,931
+4.03% (+83,360)
+0.07%
2025 Q4
1.58%
2,069,309
$21.70
$44,904,005
-9.06% (-206,220)
-0.18%
2025 Q3
1.35%
2,275,529
$15.13
$34,428,754
-50.00% (-2,275,528)
-1.48%
2025 Q2
2.21%
4,551,057
$11.27
$51,290,412
-16.36% (-890,110)
-0.51%
2025 Q1
2.78%
5,441,167
$10.09
$54,901,375
+3.23% (+170,100)
+0.09%
2024 Q4
3.21%
5,271,067
$11.83
$62,356,723
-0.70% (-36,973)
-0.02%
2024 Q3
2.55%
5,308,040
$11.54
$61,254,781
+10.33% (+497,080)
+0.24%
2024 Q2
2.49%
4,810,960
$10.57
$50,851,847
+14.81% (+620,470)
+0.32%
2024 Q1
2.02%
4,190,490
$10.54
$44,167,765
new
+2.02%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.